INTRODUCTION
Immunoglobulin G4 (IgG4)-related disease is a newly named multi-organ fibroinflammatory condition characterized by tumefactive lesions that contain dense lymphoplasmacytic infiltrates rich in IgG4-positive cells. [1] [2] [3] It is often drome, and IgG4-syndrome. 6 An agreement on the name "IgG4-related disease" was recently reached for this multifocal disorder by Japanese investigators, and since then has found worldwide use. 2, [6] [7] Inclusion of IgG4 in the terminology of the disease should not lead clinicians to make a diagnosis solely based on elevated serum IgG4 or on increased tissue IgG4-positive plasma cell infiltration. 6 Rather, the diagnosis of IgG4-related disease should continue to be made by a combination of clinical, serological, and histopathological examinations, including light microscopic features and IgG4 staining. 6, 7 Stone et al. 6 suggested that IgG4-related disease is analogous to sarcoidosis, another systemic disease in which diverse organ manifestations are linked by the same histopathological characteristics. 1 
The IgG4 molecules
IgG4 is the least abundant IgG subclass, accounting for less than 5% of total IgG in healthy individuals. 1 
Pathologic consensus statement
In parallel with the consensus diagnostic criteria proposed by internist societies, pathologists have published a consensus statement on the pathology of IgG4-related disease. 
DISEASE SPECTRUM AND PREFERRED NOMENCLATURE
IgG4-related disease generally affects middle-aged to elderly men, rather than young women. 2 The disorder usually presents in a subacute manner and its clinical symptoms can be relatively mild because the disorder is characterized by swollen but painless organs. 8 Fatigue and weight loss of 5-10 kg can occur over months, whereas patients with IgG4-related disease rarely present with fever. 3, 8 The diagnosis of IgG4-related disease can, therefore, take several months or even years after vague manifestation. This disease is often identified incidentally through radiologic findings or unexpectedly in pathological specimens. 1 Specific recommendations for virtually every IgG4-related organ system nomenclature were proposed by an organizing committee comprising international experts of clinicians, pathologists, radiologists, and basic scientists (Table 1) . 6 The recommended preferred nomenclature employs "IgG4-related-" as a prefix for individual organ involvement, regardless of the organ system affected. 6 For example, Mikulicz disease was positioned as IgG4-related dacryoadenitis and sialadenitis.
Pancreatic manifestation, however, has retained the designation "type 1 AIP (IgG4-related pancreatitis)" because type 1 AIP is a widely accepted designation among gastroenterologists and pancreatic surgeons. 6, 8 The term "IgG4-related pancreatitis" is added in parentheses for the purpose of educating the broader medical community about the relationship between IgG4-related disease and this subset of pancreatic disease. 6 
DIAGNOSTIC CRITERIA
The current comprehensive diagnostic criteria for IgG4-related disease are the diagnostic criteria for IgG4-related disease first proposed by a consensus of Japanese experts in 2011 (Table 2) . 7 Comprehensive diagnostic criteria for IgG4-related disease may be significant in the sense that IgG4-related disease is an entity of systemic disease that involves multiple organs and one diagnostic criterion may be ideal for one disease entity. However, comprehensive diag- However, it is important to differentiate IgG4-related disease from malignant tumors of each organ (e.g. cancer, lymphoma) and similar disease (e.g.
Sjögren's syndrome, primary sclerosing cholangitis, Castleman's disease, secondary retroperitoneal fibrosis, Wegener's granulomatosis, sarcoidosis, Churg-Strauss syndrome) by additional histopathological examination. Even when patients cannot be diagnosed using the comprehensive clinical diagnostic criteria, they may be diagnosed using organ-specific diagnostic criteria for IgG4-related disease.
IgG4, Immunoglobulin G4; HPF, high-power field. Organ specific diagnostic criteria can be applied before, in place of, or after the use of comprehensive diagnostic criteria for IgG4-related disease. is recommended by Japanese investigators. 16 Although majority of patients with IgG4-related disease respond to glucocorticoid therapy, they commonly experience relapse of disease. 1, 16 Most patients with disease relapse respond to a course of glucocorticoid therapy with similar remission rates achieved at the time of initial disease presentation. [17] [18] For patients who relapse, steroids are often given at a higher induction dose which is tapered more gradually, and maintenance therapy is often more prolonged. [19] [20] Azathioprine, mycophenolate mofetil, and methotrexate can be used for glucocorticoid-sparing effect or achieving additional immunosuppression in relapsed patients. 1,3,18 B cell depleting agent rituximab can also be an alternative for patients with recurrent or refractory disease. 18 Although patients with IgG4-related disease was reported to be at potentially high risk for cancer, long-term survival remains incompletely defined due to lack of long-term follow-up and preponderance in elderly population.
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CONCLUSION
The concept of IgG4-related disease unified a variety of medical diagnoses previously regarded as being confined to single organ systems. 1, 6 Swollen, but painless, organs are a common manifestation of this disorder. The awareness of 
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